Clinical Trials Browser

Phase 2/3 × Completed × Neuroendocrine Tumors × Clear all

NCT00442533 2023-04-03

Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors

Phase 2/3 Completed

CNSEndocrineNET

Carcinoid Tumor, Paraganglioma, Pheochromocytoma, Somatostatinoma, Neuroendocrine Tumors

NCT03590119 2022-11-08

LUTIA

Phase 2/3 Completed

Neuroendocrine Tumors

NCT04552847 2022-02-17

Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

Phase 2/3 Completed

Neuroendocrine Tumors